GLP-1 and Constipation: Why It Happens and What Helps
Disclaimer: Compounded semaglutide and tirzepatide are prepared by licensed 503A compounding pharmacies and have not been reviewed or approved by the FDA. This article is for educational purposes only, is not medical advice, and does not establish a provider-patient relationship. Talk to your provider before changing your medication or regimen.
Constipation is one of the most common reasons patients message after starting a GLP-1 medication. It is also one of the most manageable, and rarely a reason to stop treatment. Once you understand why it happens, the solutions are obvious.
Why GLP-1 Medications Cause Constipation
The same mechanism that makes these medications effective for weight loss is the one that causes the constipation. That is worth understanding, because it reframes the side effect from something alarming into something expected and addressable.
GLP-1 receptor agonists slow gastric emptying and reduce the motility of the stomach and intestines.[1] This is a core part of how they work: by slowing the movement of food through your system, they prolong the feeling of fullness and blunt appetite. Slower transit through the gut is the point.
The downside is that slower intestinal motility also means stool spends more time in the colon, where more water is reabsorbed from it, and the result is harder, less frequent bowel movements. Gastrointestinal side effects are the most common class of adverse effects with these medications, reported in a substantial share of patients, and while nausea and diarrhea are frequently discussed, constipation is a well-documented member of that group, particularly at higher doses.[1][2]
The Good News: It Is Usually Manageable and Often Temporary
Two things are worth knowing up front. First, these side effects are frequently dose-dependent and tend to be most noticeable when starting or increasing a dose, often easing as the body adapts. Second, the standard management strategies are simple, low-risk, and effective for most people.
Our practice generally starts with the conservative measures below, and they resolve the great majority of cases without any change to the medication.
What Helps
Increase water intake. This is first for a reason. Since the problem is partly about water being pulled from stool during slow transit, staying well hydrated directly counteracts it. Many patients on GLP-1 medications drink less than they used to, because reduced appetite often comes with reduced thirst awareness. Deliberate hydration matters.
Increase dietary fiber. Increasing fiber intake is a standard, evidence-supported recommendation for GLP-1-associated constipation.[2] Fiber adds bulk and helps stool move. Build it up gradually rather than all at once, since a sudden large increase can cause bloating.
Keep moving. Physical activity supports intestinal motility. Even regular walking helps, and it complements the weight-loss goals of the therapy.
Consider a stool softener if needed. When diet and hydration are not enough, over-the-counter stool softeners are a reasonable next step and are commonly recommended for this situation.[2] This is a conversation to have with your provider, who can advise on what fits your situation.
Eat smaller, more frequent meals. Because these medications slow gastric emptying, large meals sit heavily. Smaller, more frequent meals ease the whole GI system and reduce several side effects at once.[1]
When to Talk to Your Provider
Most constipation is a nuisance that resolves with the steps above. But certain symptoms warrant prompt medical attention rather than self-management: severe or persistent abdominal pain, a complete inability to pass stool or gas, significant bloating with vomiting, or symptoms that are worsening rather than improving. These are uncommon, but they are reasons to reach out promptly rather than wait.
If conservative measures are not working, your provider can also consider adjusting the dose. Sometimes slowing the titration schedule resolves the issue while keeping you on track.[2] That is a clinical decision, and it is exactly the kind of thing our team is here to help with.
The Bottom Line
Constipation on a GLP-1 medication is common, expected, and usually a direct consequence of the slowed gut motility that makes the medication work. For most people it is manageable with more water, more fiber, movement, and if needed a stool softener, and it often eases as your body adapts. It is rarely a reason to abandon a therapy that is working. If it is not improving with these steps, talk to your provider before making any changes.
For more on managing GI effects, see our article on tirzepatide and constipation. To learn about our programs, visit our compounded semaglutide and compounded tirzepatide pages, and reach out to our providers with any concerns.
References
1. Maselli DB, Camilleri M. Effects of GLP-1 and its analogs on gastric physiology in diabetes mellitus and obesity. Adv Exp Med Biol. 2021;1307:171-192. PubMed: 32077010
2. Wharton S, Davies M, Dicker D, et al. Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: recommendations for clinical practice. Postgrad Med. 2022;134(1):14-19. PubMed: 34775881
This article is for educational purposes only and does not constitute medical advice or establish a provider-patient relationship. Compounded medications have not been reviewed by the FDA and are not the same as commercially available FDA-approved products. Please consult a licensed provider.
